Increased state-level regulation potentially on the horizon
On January 23, 2025, President Donald Trump signed the Executive Order (EO) Removing Barriers to American Leadership in Artificial Intelligence. The artificial intelligence (AI)- focused EO is
Continue Reading White House AI Executive Order sets its sights on free-market innovation
Following President Donald Trump’s January 21, 2025 Executive Order (EO) titled, “Ending Illegal Discrimination and Restoring Merit-Based Opportunity,” recent federal developments may impact how companies approach their review of existing diversity, equity, and inclusion (DEI)
Continue Reading President Trump’s DEI Executive Orders: Recent developments for employers to know
The restructuring landscape in 2024 demonstrated dynamic shifts, with courts across jurisdictions issuing pivotal rulings that helped reshape bankruptcy law. Our alert provides a recap of our coverage of key rulings, major cases, and evolving
Continue Reading Impactful rulings and cases shaping bankruptcy law: 2024 restructuring recap
The US Food and Drug Administration (FDA) recently issued its draft guidance, Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations on January 7, 2025. The draft guidance provides insights on how FDA
The incoming administration could bring significant, fast-evolving changes to US tariff policy. Our alert, written before President Trump took office, explores the potential implications of these policies, and what US importers and their business
Continue Reading Tariffs and Trump: Preparing your business to mitigate duties
Time is running out for Corporate Transparency Act (CTA) compliance. The law, which became effective on January 1, 2024, requires certain entities – or “reporting companies” – to disclose information about their beneficial ownership to
Changes to the tax code have made it easier to monetize renewable energy tax credits, attracting interest from emerging growth companies looking to bolster their balance sheets amid the slowdown in venture capital funding. These
The month in life sciences and intellectual property
In our most recent Synthesis issue, the month in life sciences and intellectual property news: Defining the limits of protection that skinny labels afford; the impact of
Continue Reading Synthesis, Issue 5
On September 28, 2024, California enacted SB 1120, which regulates the use of artificial intelligence (AI), an algorithm, or “other software tool” in utilization review and utilization management (UR/UM) functions by healthcare service plans (HCSPs)
Continue Reading California implements new AI and software regulations for insurers
